In conclusion, our results showed increased expression of MCM3 in endocrine-resistant breast cancer cell lines, and that this upregulation plays a significant role in protecting cells against tamoxifen- or letrozole-mediated growth inhibition and apoptosis. This evidence concerns the gene MCM3 and breast cancer.